There have been very many studies looking at the effects of lowering serum cholesterol, of which here trials such as the MRFIT, POSCH, Scandinavian Simvastatin Survival study, CARE trial, VA-HIT, WOSCOPS and MRC/BHF Heart Protection study are briefly reviewed. These show that reduction of cholesterol is worthwhile in primary and secondary prevention of coronary heart disease (CHD).
Some trials involving lipid lowering treatments are linked below.
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.